Your session is about to expire
← Back to Search
Health Coaching for Breast Cancer Survivors
N/A
Recruiting
Led By Bridget A Oppong, MD
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Black women > 18 years of age with stage I-III primary breast cancer who have completed definitive breast cancer treatmen
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights
Study Summary
This trial is testing a navigation program to help Black breast cancer survivors access physical, emotional, and nutritional support and improve their quality of life.
Who is the study for?
This trial is for Black women over the age of 18 who have been treated for stage I-III primary breast cancer and are now finished with their main treatment. It's designed to support these survivors as they transition out of active treatment.Check my eligibility
What is being tested?
The study tests a coaching-based navigation program that helps participants access resources for physical rehab, emotional support, and guidance on nutrition and exercise to potentially improve their quality of life after breast cancer treatment.See study design
What are the potential side effects?
Since this trial involves patient navigation and lifestyle coaching rather than medical treatments, there are no direct side effects like those associated with drugs or surgery. However, participants may experience varying levels of psychological impact.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Breast Cancer Self Efficacy Scale score
Consent rate
Dropout rate
+3 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Health services research (patient navigator)Experimental Treatment3 Interventions
Patients are assigned a Black patient navigator for racial concordance and receive coaching from patient navigator over 30 minutes every other week for 3 months and then monthly for 3 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient Navigation
2017
Completed Phase 2
~38910
Find a Location
Who is running the clinical trial?
Ohio State University Comprehensive Cancer CenterLead Sponsor
320 Previous Clinical Trials
290,127 Total Patients Enrolled
22 Trials studying Breast Cancer
2,884 Patients Enrolled for Breast Cancer
Bridget A Oppong, MDPrincipal InvestigatorOhio State University Comprehensive Cancer Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Black women over 18 years old with early-stage breast cancer who have finished their main breast cancer treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Health services research (patient navigator)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are physicians currently recruiting volunteers for this medical experiment?
"According to the details provided by clinicaltrials.gov, this research initiative is actively recruiting participants. It was publicly announced on November 14th 2022 and last updated on December 21st 2022."
Answered by AI
What is the scope of participation in this research endeavor?
"Affirmative. Clinicaltrials.gov's data suggests that this clinical trial, initially posted on November 14th 2022, is recruiting participants. Approximately 40 individuals must be recruited from 1 medical site."
Answered by AI
Share this study with friends
Copy Link
Messenger